APPLICATION
ANDA062338
TYPE
ANDA
ORIGINAL APPROVAL
1981-05-22
LATEST ACTION
2000-12-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED REL PELLETS
MARKETING STATUS
Discontinued
Products
ERYCDiscontinued
ERYTHROMYCIN 250MG · CAPSULE, DELAYED REL PELLETS · ORAL
Approval history
2000-12-21Manufacturing (CMC) · Supplement 11AP
2000-09-12Manufacturing (CMC) · Supplement 10AP
1998-02-06Manufacturing (CMC) · Supplement 9AP
1997-07-31Manufacturing (CMC) · Supplement 8AP
1991-05-17Labeling · Supplement 5AP
1981-05-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.